SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis
Ke Jiang1, Peng Liu2,3, Huizhe Xu1
1Institute of Cancer Stem Cell, Dalian Medical University Cancer Center, 116044, Dalian, China.
Abstract:
Triple-negative breast cancer (TNBC) is extremely aggressive and lacks effective therapy. SAM and SH3 domain containing1 (SASH1) has been implicated in TNBC as a candidate tumor suppressor; however, the mechanisms of action of SASH1 in TNBC remain underexplored. Here, we show that SASH1 was significantly downregulated in TNBC patients samples compared with other subtypes of breast cancer. Ectopic SASH1 expression inhibited, while depletion of SASH1 enhanced, the invasive phenotype of TNBC cells, accompanied by deregulated expression of MMP2 and MMP9. The functional effects of SASH1 depletion were confirmed in the chicken chorioallantoic membrane and mouse xenograft models. Mechanistically, SASH1 knockdown downregulated the phosphorylation levels of the Hippo kinase LATS1 and its effector YAP (Yes associated protein), thereby upregulating YAP accumulation together with its downstream target CYR61. Consistently, forced SASH1 expression exhibited opposite effects. Pharmacological inhibition of YAP or knockdown of YAP reversed the enhanced cell invasion of TNBC cells following SASH1 depletion. Furthermore, SASH1-induced YAP signaling was LATS1-dependent, which in reverse enhanced phosphorylation of SASH1. The SASH1 S407A mutant (phosphorylation deficient) failed to rescue the altered YAP signaling by SASH1 knockdown. Notably, SASH1 depletion upregulated ARHGAP42 levels via YAP-TEAD and the YAP-ARHGAP42-actin axis contributed to SASH1-regulated TNBC cell invasion. Therefore, our findings uncover a new mechanism for the tumor-suppressive activity of SASH1 in TNBC, which may serve as a novel target for therapeutic intervention.
Insights
Triple-negative breast cancer (TNBC) progression is linked to low SASH1 levels. Restoring SASH1 suppresses invasion by regulating the Hippo-YAP pathway, offering a potential therapeutic target for aggressive TNBC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype lacking effective therapies.
- SAM and SH3 domain containing 1 (SASH1) is a potential tumor suppressor in TNBC, but its mechanisms are unclear.
- SASH1 is significantly downregulated in TNBC compared to other breast cancer subtypes.
Purpose of the Study:
- To elucidate the mechanism of SASH1's tumor-suppressive activity in TNBC.
- To investigate the role of SASH1 in regulating TNBC cell invasion and the Hippo-YAP pathway.
- To identify SASH1 as a potential therapeutic target for TNBC.
Main Methods:
- Analysis of SASH1 expression in TNBC patient samples.
- In vitro studies using TNBC cell lines with SASH1 ectopic expression or depletion.
- In vivo validation using chicken chorioallantoic membrane and mouse xenograft models.
- Investigation of the Hippo-YAP signaling pathway, including LATS1, YAP, CYR61, and ARHG42.
- Pharmacological inhibition and knockdown of YAP.
- Site-directed mutagenesis of SASH1 (S407A mutant).
Main Results:
- SASH1 depletion enhanced TNBC cell invasion, correlating with increased MMP2 and MMP9 expression.
- SASH1 knockdown led to decreased LATS1 phosphorylation and increased YAP accumulation, upregulating YAP targets like CYR61 and ARHG42.
- Inhibition or knockdown of YAP reversed the invasive phenotype induced by SASH1 depletion.
- SASH1-regulated YAP signaling was LATS1-dependent, with SASH1 phosphorylation influencing this interaction.
- The YAP-ARHG42-actin axis was identified as a key mediator of SASH1-regulated TNBC cell invasion.
Conclusions:
- SASH1 acts as a tumor suppressor in TNBC by inhibiting cell invasion.
- SASH1 regulates TNBC cell invasion through the LATS1-YAP-ARHG42 axis.
- Targeting SASH1 or the downstream YAP pathway presents a potential therapeutic strategy for TNBC.
More Related Videos
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
The JAK-STAT Signaling Pathway
Cancer Cell Migration through Invadopodia
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Anaphase Promoting Complex
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
